MALIGNANT NEOPLASMS OF THYROID AND OTHER ENDOCRINE GLANDS
Clinical trials for MALIGNANT NEOPLASMS OF THYROID AND OTHER ENDOCRINE GLANDS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASMS OF THYROID AND OTHER ENDOCRINE GLANDS trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASMS OF THYROID AND OTHER ENDOCRINE GLANDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to stall tough cancers
Disease control OngoingThis study tests a combination of two drugs, selumetinib and olaparib, in people with advanced or recurrent solid tumors (including breast, digestive, female/male genital, and thyroid cancers). The goal is to find the safest dose and see if it can help control the cancer. Up to 9…
Matched conditions: MALIGNANT NEOPLASMS OF THYROID AND OTHER ENDOCRINE GLANDS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:24 UTC
-
Bacteria bombs target Hard-to-Treat tumors in new combo therapy
Disease control OngoingThis early-phase study tests a special bacteria (Clostridium novyi-NT) injected directly into tumors, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors that haven't responded to standard treatments. The goal is to find the safest dose and s…
Matched conditions: MALIGNANT NEOPLASMS OF THYROID AND OTHER ENDOCRINE GLANDS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:20 UTC